By Ed Devlin2026-02-25T08:01:00
Organic revenue growth came in lower than expectations for 2025 at 3%, with the performance also affected by depressed consumer confidence in North America, where volumes declined 1.4%
A drop-off in demand for cold & flu medication has held back growth at consumer health group Haleon.
Already have an account? Sign in here
Already have an account? Sign in here